Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-02

Clinical Trial Update: Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a transdermal estradiol patch for ovulation induction in women with Premature ovarian failure has been withdrawn. No results were repor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estradiol transdermal patch (estradiol)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Premature Ovarian Failure | Phase 2 | Status: WITHDRAWN